Finally, the expression levels of the matrix-degrading enzyme metalloproteinase-2 (MMP-2), one of the promoters of tumor cell invasion, were also found to be more reduced after combined treatment with the two drugs compared with the single agents. Here, MMP2 is linked to neoplasm.